[1] |
中华医学会器官移植学分会.中国肝癌肝移植临床实践指南[J/CD].中华危重症医学杂志:电子版,2014,52(6):497-501.
|
[2] |
李玉民,焦作义,张冬红,等.重视肝移植患者术后乙型病毒性肝炎复发的预防工作[J/CD].中华肝脏外科手术学电子杂志,2013,2(5): 277-280.
|
[3] |
张勤.肝移植术后预防乙肝复发的治疗进展[J].长治医学院学报,2013,27(3): 238-240.
|
[4] |
Fox AN, Terrault NA. The option of HBIG-free prophylaxis against recurrent HBV[J]. J Hepatol, 2012, 56(5):1189-1197.
|
[5] |
高银杰,刘振文,张敏,等.恩替卡韦联合人免疫球蛋白预防肝移植后乙肝复发[J].中国组织工程研究,2013,17(31): 5588-5594.
|
[6] |
熊璐,郭晓东,高银杰,等.肝移植术后替米夫定联合乙肝免疫球蛋白预防乙肝复发的研究[J].现代生物医学进展,2013,13(8): 1498-1499, 1535.
|
[7] |
中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南( 2015年版) [J/CD].中华实验和临床感染病杂志:电子版,2015,9(5): 570-589.
|
[8] |
Fung J, Chan SC, Cheung C, et al. Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B[J]. Am J Gastroenterol, 2013, 108(6): 942-948.
|
[9] |
McCaughan GW. Prevention of post liver transplant HBV recurrence[J]. Hepatol Int, 2011, 5(4):876-881.
|
[10] |
Cholongitas E, Papatheodoridis GV. High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review[J]. Am J Transplant, 2013, 13(2): 353-362.
|
[11] |
Wadhawan M, Gupta S, Goyal N, et al. Living related liver transplantation for hepatitis B-related liver disease without hepatitis Bimmune globulin prophylaxis[J]. Liver Transpl, 2013, 19(9):1030-1035.
|
[12] |
陈焕伟,邓斐文,甄作均.核苷类似物单药口服预防肝移植术后乙型病毒性肝炎复发的研究[J].器官移植,2014,5(5): 308-313.
|
[13] |
姜华,杨扬,杨林,等.肝移植围手术期外周血单个核细胞内乙型肝炎病毒DNA的检测及临床价值[J].中华实验外科杂志,2008,25(11): 1404-1406.
|
[14] |
Perrillo R, Buti M, Durand F, et al. Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation forchronic hepatitis B[J]. Liver Transpl, 2013, 19(8):887-895.
|
[15] |
王凯,高伟,马楠,等.乙型肝炎表面抗原阳性供肝在肝癌患者肝移植中的应用[J].中华器官移植杂志,2015,36(9): 536-539.
|
[16] |
陈新国,沈中阳,牛玉坚,等.HBsAg阳性供者供肝用于乙型肝炎合并超UCSF标准肝癌肝移植20例[J].中华器官移植杂志,2013,34(9): 528-531.
|
[17] |
Yu S, Yu J, Zhang W, et al. Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation[J]. J Hepatol, 2014, 61(4): 809-815.
|
[18] |
Fung J, Cheung C, Chan SC, et al. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation[J]. Gastroenterology, 2011, 141(4):1212-1219.
|
[19] |
段斌炜,卢实春,武聚山,等.肝移植术后乙肝主动免疫重建受体停用乙肝免疫球蛋白和(或)抗病毒药物的可行性[J].北京医学,2015,37(12): 1139-1141.
|
[20] |
涂志越,孙丽莹,朱志军,等.儿童活体肝移植受者术后新发乙型肝炎病毒感染的临床研究[J].器官移植,2015,6(4): 245-248,267.
|